About us
What we do
Our strategy
Market opportunity
Our team
Our History
Origins – Institute of Cancer Therapeutics (ICT) Bradford
Pipeline
Our products
For patients
Partnering
Our partnerships
Investors
Overview
Why invest?
IPO materials
Regulatory news
Results, Reports and Presentations
Research Notes
Email alerts
Share price and tools
Financial calendar
Shareholder information
Investor and Advisor contacts
AQSE Growth Market Rule 4.14
Corporate Governance
Company Contact Details
News & media
News
Press Coverage
Scientific Publications
Contact Us
Sustainability
Share price
INC 04.00 GBp
About us
What we do
Our strategy
Market opportunity
Our team
Board of Directors
Senior Management
Advisors and Founders
Our History
Origins – Institute of Cancer Therapeutics (ICT) Bradford
Pipeline
Our products
For patients
Partnering
Our partnerships
Investors
Overview
Why invest?
IPO materials
Regulatory news
Results, Reports and Presentations
Research Notes
Email alerts
Share price and tools
Share price chart
Detailed share price
Financial calendar
Shareholder information
Shareholder Information
AGM
GM
Analyst coverage
Investor and Advisor contacts
AQSE Growth Market Rule 4.14
Corporate Governance
Corporate Governance Report
QCA Corporate Governance Principles
Company Contact Details
News & media
News
Press Coverage
Scientific Publications
Contact Us
Sustainability
Latest from Incanthera
Home
News & media
Latest from Incanthera
Latest from Incanthera
2024
2023
2022
Archive
November 26th, 2024
Commercial Update
October 29th, 2024
Further re: Commercial Update
October 17th, 2024
Result of AGM 2024
September 26th, 2024
Commercial Update
September 25th, 2024
Notice of Annual General Meeting 2024 and Posting of Annual Report and Accounts
Download PDF
August 27th, 2024
Final Results for the year ended 31 March 2024
Prev
1
2
3
Next